...
首页> 外文期刊>International Biological and Biomedical Journal >Mediator Complex Subunit 12 Gene Polymorphisms in Uterine Fibroids and Breast Fibroadenomas in Senegalese Women
【24h】

Mediator Complex Subunit 12 Gene Polymorphisms in Uterine Fibroids and Breast Fibroadenomas in Senegalese Women

机译:塞内加尔妇女子宫肌瘤和乳腺纤维腺瘤中的介体复合物亚基12基因多态性。

获取原文

摘要

Mediator complex subunit 12 (MED12) is a part of the mediator complex, which is believed to regulate transcription. MED12 is mutated at high frequency and with different mutation frequencies in uterine fibroids and breast fibroadenomas of different populations. This study aimed to analyze MED12 mutations in Senegalese population. MED12 was sequenced in the tumoral tissues and blood samples of Senegalese women with uterine fibroids or breast fibroadenomas. Surveyor software version 5.0.1, DnaSP version 5.10, MEGA version 6.06 and Arlequin version 3.5.1.3 were used to determine the level of mutations and genetics parameters. Our results showed the presence of variants in the tumoral tissues only, with most of them being heterozygous single nucleotide polymorphisms. Deletion in polyA tail was identified for the first time in the studied population. Data also showed that MED12 exon 2 was under positive selection in case of uterine fibroids and breast fibroadenomas. The variants frequencies were not similar to those found in the Finnish or Southern United States populations for cases of uterine fibroids, and to Japanese population for cases of breast fibroadenomas. These results suggest that MED12 variants could contribute to the development of uterine fibroids and breast fibroadenomas. The present study contributes to the current information on MED12 variations in different populations and may aid in the development of personalized diagnoses for patients with uterine fibroids or breast fibroadenomas in the future.
机译:介体复合物亚基12(MED12)是介体复合物的一部分,据信它可调节转录。 MED12在不同人群的子宫肌瘤和乳腺纤维腺瘤中发生高频突变,并且具有不同的突变频率。这项研究旨在分析塞内加尔人口中的MED12突变。在具有子宫肌瘤或乳腺纤维腺瘤的塞内加尔妇女的肿瘤组织和血液样本中对MED12进行测序。使用Surveyor软件版本5.0.1,DnaSP版本5.10,MEGA版本6.06和Arlequin版本3.5.1.3来确定突变水平和遗传学参数。我们的结果表明,仅在肿瘤组织中存在变体,其中大多数是杂合的单核苷酸多态性。在研究人群中首次鉴定出polyA尾巴中的缺失。数据还显示,对于子宫肌瘤和乳腺纤维腺瘤,MED12外显子2处于阳性选择状态。子宫肌瘤病例的变异频率与芬兰或美国南部人群的乳腺纤维腺瘤病例的变异频率不同,而日本人群的变异频率与日本人群相似。这些结果表明,MED12变异可能有助于子宫肌瘤和乳腺纤维腺瘤的发展。本研究有助于了解有关不同人群中MED12变异的最新信息,并可能有助于将来对子宫肌瘤或乳腺纤维腺瘤患者进行个性化诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号